Whenever Mark Moran, chief executive officer of the investor relations firm Equity Animal, is about to perform a boring task, he has a ritual. He pops a Zyn nicotine pouch into his mouth. Then his concentration sharpens, at least for a while. “Am I addicted to it? Absolutely,” he said. “But it’s…